For example, when combining BET inhibitors and mTOR inhibitors, thrombocytopenia is a common adverse effect of these two groups of medicines; therefore, the problem of superimposed side effects from both drugs must be considered when using them in combination.44 This evidence concerns the gene DNER and Thrombocytopenia.